Clin Assoc Prof Peng Kaitian

Dr Peng Kaitian is an Associate Consultant with the Paediatric Allergy Service, Department of Paediatric Medicine, KK Women’s and Children’s Hospital (KKH). She received her medical degree from the Duke-NUS Graduate Medical School in 2016 and obtained her post-graduate Paediatric Medicine qualifications from the Royal College of Paediatrics and Child Health, UK and National University of Singapore in 2021. Dr Peng received her Paediatrics specialist accreditation in 2025.

Dr Peng specialises in paediatic allergy and her research interests include food and drug allergies in children, oral immunotherapy and immunomics of allergies.

A recipient of the prestigious National Science Scholarship from A*STAR, Dr Peng graduated with a BSc-First Class Honors degree from the Imperial College, London, UK in 2005 and her PhD degree in Microbiology and Immunology from Stanford University, USA in 2011. Her PhD was supervised by Prof Denise Monack at the Stanford Medical School (now Martha Meier Weiland Professor of School of Medicine, Stanford University, USA). Dr Peng was a research scientist in the Singapore Immunology Network, A*STAR, Singapore from 2011-2013, under Prof Laurent Renia (now executive director of Infectious Diseases Labs, A*STAR).

Dr Peng has published several review articles as well as numerous journal articles in Journal of Immunology, PLoS, Infection and Immunity, Cell Microbiology etc. She is the recipient of multiple global and national awards.

Apart from clinical and research work, Dr Peng is also a passionate educator, actively involved in medical education with the Yong Loo Lin School of Medicine, Duke-NUS Medical School and Lee Kong Chian School of Medicine. She has also supervised undergraduate and postgraduate students from Imperial College, London (UK), National University of Singapore, Nanyang Technological University (Singapore) in their research work and was involved in postgraduate education at the School of Medicine, Stanford University (USA).

• MRCPCH (UK), Royal College of Paediatrics and Child Health, 2021
• MMed (Paediatrics), National University of Singapore, 2021
• MD, Duke-NUS Graduate Medical School (Singapore), 2013
• PhD, Stanford University (USA), 2011
• BSc-First Class Hons, Imperial College, London, UK, 2005

• Associate Consultant, Allergy Service, Department of Paediatrics, KK Women’s and Children’s Hospital (2025-Present)
• Member, Allergy & Clinical Immunology Society of Singapore (2025-Present)
• Member, Royal College of Paediatrics and Child Health (UK) (2025-Present)
• Member, Asia Pacific Association of Paediatric Allergy, Respirology and Immunology (2025-Present)
• Adjunct Research Fellow, Duke-NUS Medical School, Singapore (2018-Present)
• Member, Royal College of Science (UK) (2005-Present)

• RISE Award, SingHealth 2022
• Seah Cheng Siang Gold Medal in Internal Medicine, Duke-NUS Medical School, 2016
• Prize in Paediatrics, Duke-NUS Medical School, 2016
• Community Service Commendation Award, People’s Association Singapore, 2013
• Professor Sidney Raffel Award, Stanford University, USA, 2011
• National Science Scholarship, BS-PhD, A*STAR Singapore, 2002-2011

• Immunomics of food allergies

• Peng K, Goh YS, Siau A, Franetich JF, Chia WN, Ong AS, Malleret B, Wu YY, Snounou G, Hermsen CC, Adams JH, Mazier D, Preiser P, Sauerwein RW, Gruner AC, Renia L. Cell Microbiol. 2016. 18(12): 1739-1750. Breadth of the humoral response and antigenic targets of sporozite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.
• Goh YS, Peng K, Chia WN, Siau A, Chotivanich K, Gruner AC, Priser P, Mayxay M, Pukrittayakamee S, Sriprawat K, Nosten F, White NJ, Renia L. PLoS One. 2016. 11(7): e0159347. Neutralizing antibodies against Plasmodium falciparum associated with successful cure after drug therapy
• Peng K, Broz P, Jones J, Joubert LM, Monack DM. Cell Microbiol. 2011. 13: 1586-600. Elevated AIM2 mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis.
• Lindemann S, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen LAH, Jones BD. Infect Immun. 2011. 79: 581-94. Francisella tularensis mutants in O-antigen and capsule biosynthesis genes induce early cell death in human macrophages.
• Peng K and Monack DM. Infect Immun. 2010; 78: 2723-33. Indoleamine 2,3 dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophs. [Research Highlights, Infect Immun 2010; 78: 2355]
• Claser C, Malleret B, Peng K, Bakocevic N, Gun SY, Russell B, Ng LG, Renia L. Parasitol Int. 2014. 63: 187-94. Rodent Plasmodium-infected red blood cells: imaging their fates and interactions within their hosts.
• Mauduit M, See P, Peng K, Renia L, Ginhoux F. Immunol Res. 2012. 53: 115-26. Dendritic cells and the malaria pre-erythrocytic stage.
• Henry T, Kirimanjeswara GS, Ruby T, Jones JW, Peng K, Perret M, Ho L, Sauer JD, Iwakura Y, Metzger DW, Monack DM. J. Immunol. 2010; 184: 3755-67. Type I IFN signaling constraints IL-17A/F secretion by gammadelta T cells during bacterial infections.
• McLaughlin LM, Govoni GR, Gerke C, Gopinath S, Peng K, Laidlaw G, Chien YH, Jeong HW, Li Z, Brown MD, Sacks DB, Monack DM. PLoS Pathog. 2009; 5: e1000671. The Salmonella SPI2 effector sseI mediates long-term systemic infection by modulating host cell migration
• Ruhe JE, Streit S, Hart S, Wong CH, Specht K, Knyazev P, Knyazeva T, Tay LS, Loo HL, Foo P, Wong W, Pok S, Lim SJ, Ong H, Luo M, Ho HK, Peng K, Lee TC, Bezler M, Mann C, Gaertner S, Hoefler H, Iacobelli S, Peter S, Tay A, Brenner S, Venkatesh B, Ullrich A. Cancer Res. 2007; 67: 11368-76. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.
• Wiles S, Pickard KM, Peng K, MacDonald TT, Frankel G. Infect. Immun. 2006; 74: 5391-6. In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium.
• Tan EC, Chong SA, Tan CH, Teo YY, Peng K, Mahendran R. Biol Pyschiatry. 2003; 54: 1205-11. Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia.